Introduction
The hematopoietic system has been conceptualized as operating within a hierarchical model, with the hematopoietic stem cell (HSC) at the apex. 1 Human umbilical cord blood (CB) CD34 2 cells would appear to be the most quiescent HSCs capable of giving rise to CD34 1 CD90 low CD49f 1 HSCs with long-term reconstituting ability. [2] [3] [4] Whether HSCs are affected by Notch signaling remains controversial. For instance, Notch signaling does not appear to be required for the maintenance of adult HSCs in mice. 5 In contrast, Notch signaling was shown to play an important role in the expansion of self-renewing HSCs in vitro. 6 In humans, although a prominent role for Notch signaling is well documented based on the expansion of CD34 1 cells in vitro, which includes both HSCs and progenitor cells, no quantitative and functional direct comparison in the efficiency of reconstitution to fresh ex vivo HSCs has been reported. [7] [8] [9] [10] [11] [12] [13] Nonetheless, Notch appears to affect human HSCs because CD34 2/1 HSCs were recently shown to have active Notch signaling. However, in contrast to the experimental approach used in mice, which shows that Notch is not required for HSC maintenance, no similar genetic manipulations have been reported for human HSCs. 4, 5 Several human progenitors able to differentiate into lymphomyeloid cells have been found in CB and/or bone marrow (BM). [14] [15] [16] [17] [18] Nevertheless, it remains difficult to establish a clear hierarchical structure starting from an HSC. We sought to address this by starting cultures with purified CB-derived HSCs and functionally defined intermediates to yield a composite and hierarchical relationship. We modified the OP9-DL1 cell coculture system 19, 20 to support the expansion of HSCs and made use of OP9 cells expressing 2 different levels of Delta-like-4 (Dll4), 21 therefore enabling the titration of Notch signaling on HSCs. Additionally, using a genetic approach, we found that Notch signaling during the coculture period was required for the maintenance of HSCs while delaying the appearance and frequency of downstream progenitors. However, in vivo competition experiments revealed that Notch signaling was not required for the maintenance of human HSCs within the BM.
Together, our findings support the notion that Notch signals can extend the period of time in which HSC function can be maintained in vitro by delaying the emergence of at least 2 early progenitors, which we have characterized here providing a more complete view of the early stages of human hematopoiesis.
Methods

Umbilical CB samples
Human CB samples were obtained by syringe extraction and collected in a blood-pack unit containing citrate phosphate dextrose anticoagulant (Baxter Healthcare) from consenting mothers following delivery in accordance with approved guidelines established by the research ethics board of Sunnybrook Health Sciences Centre. Within 24 hours of collection, CB mononuclear cells were isolated as previously described. 19 Mice NOD.cg-PrkdcscidIL2rgtm/Wjl/Sz (NOD/SCID/g c null , NSG) and Rag2 2/2 g c null BALB/c mice were purchased from The Jackson Laboratory and housed and bred in a pathogen-free facility. All animal procedures were approved by the Sunnybrook Health Science Centre Animal Care Committee.
Generation of OP9-Dll4
OP9-Ctrl, OP9-DL4 hi , and OP9-DL4 low cells were generated and maintained as previously described. 22 CB purification CB cells were lineage depleted using the Stem-Sep human progenitor cell enrichment kit (StemCell Technologies) according to the manufacturer's protocol, and further purified as described in detail in the supplemental Methods (available on the Blood Web site).
Cocultures
OP9-Ctrl, OP9-DL4
hi , and OP9-DL4 low cells were plated and maintained as previously described, [22] [23] [24] and used in cocultures as described in detail in the supplemental Methods.
For clonal analysis, sort-deposited cells were cultured for an additional 14 to 21 days under T or myeloid conditions as described in detail in the supplemental Methods.
In vivo reconstitutions
Donor cells were sorted for the indicated markers and then injected intrahepatically into neonatal immune-deficient mice irradiated with 2 Gy. After 10 weeks, mice were sacrificed and thymus, BM, and spleen were analyzed by flow cytometry. Details of the cells used and analysis are described in the supplemental Methods.
dnMaml construct and retroviral transductions
The sequence encoding for amino acids 8 to 74 from the mouse Mastermind like 1 (Maml1) gene was fused, in frame, to a 59-enhanced green fluorescent protein (eGFP) sequence using described cloning methods. This dominant-negative form of MAML1 (dnMaml) was then cloned into retroviral or lentiviral vectors to be used for transduction experiments of CB cells as described in detail in the supplemental Methods.
Precursor-product relationships
In vitro-derived CD45RA int cells were sorted on day 18 from cultures, on OP9-Dl4 hi -DL4 low or -Ctrl. Sorted cells (10 000 cells) were then cultured again on the OP9 cells they were derived from, in Stem. After 2 and 3 days, analysis of CD45RA expression on gated CD34
1
CD38
2 CD7 2 CD10 2 cells was performed.
Quantitative polymerase chain reaction analysis
Total RNA was isolated in TRIzol reagent and reverse transcribed using Superscript-III and Oligo(dT) primers (Invitrogen). Diluted complementary DNA samples from cultures were used as described in detail in the supplemental Methods.
Statistical analysis
Student t unpaired and paired 2-tailed tests were performed using Excel and Prism software.
Results
Characterization of early hematopoietic subsets in CB
We have used CB to identify early hematopoietic subsets using previously described markers, 2, 25 with the addition of Rhodamine-123 (Rho) and CD133 to further characterize human HSC and multipotent progenitor (MPP) subsets. Analysis of CD45RA expression from Lin
2
CD135
1 cells showed the presence of 3 populations, with the most abundant fraction being CD45RA
2
. As shown in Figure 1A , the CD45RA 2 fraction (CD45RA 2 cells) was further analyzed for CD133 expression and Rho uptake, and we identified the HSC fraction as having a CD90 low phenotype, which was found only in the CD45RA 21 (supplemental Figure 1C) , together with cytokines 3, 26 to support survival and expansion of HSCs and early progenitors. Cocultures were analyzed on a weekly basis for the expression of markers that define HSCs. By day 21, we noted that cocultures grown on OP9-DL4 hi and -DL4 low cells displayed a greater frequency of CD34 1 cells than those on OP9-Ctrl cells ( Figure 1B ).
An additional and expected effect of Notch signaling was the generation of CD34 Figure 1D) .
Based on these observations, we looked specifically at CD34 Figure 1F) .
We calculated the expansion of CD45RA
2 ) cells, and phenotypically defined HSCs (pHSCs) as (
low ) based on the absolute cellularity recovered from the starting HSCs (Figure 2A ). CD45RA
2 and pHSCs cultured on Ctrl expanded minimally (Figure 2A-B) . However, when cultured with DL4 hi , CD45RA
2 , and pHSCs expanded sixfold to 12-fold and twofold to fourfold after 2 to 3 weeks, respectively (Figure 2A-B) . A smaller, but significant, expansion was also seen with DL4 low . Similar data were obtained when OP9-DL1
hi cells were used (data not shown). These results suggest that a high or low level of Notch signaling retards differentiation of pHSCs, allowing for some cellular expansion. We conclude that the modified OP9-DL4 coculture system appears to maintain cells that are phenotypically identical to the input HSCs.
In vivo potential of HSCs generated in vitro
Although phenotypically defined HSCs were maintained and expanded in the presence of Notch signals in vitro, the functional potential of these cells remained to be verified. We therefore compared the capacity of isolated DL4 We next wanted to compare day 14 in vitro-grown pHSCs with freshly isolated HSCs for their ability to repopulate immunedeficient mice. NSG mice were injected with fresh HSCs ranging from 0.5 to 3 3 10 3 cells/mouse, and the resulting expansion of CD45RA 2 cells after 10 weeks within the BM of host mice was used to determine the expected cellular yield from injected HSCs ( Figure 2F ). A linear relationship was observed with the absolute number of donor CD45RA 2 cells in the BM correlating directly with the number of injected HSCs. We then extrapolated the number of CD45RA 2 cells recovered from mice injected with 2 3 10 3 day 14 in vitro-grown pHSCs and found that this corresponded to the equivalent of 0.5 3 10 3 freshly isolated HSCs, or a ;0.25 times equivalency in cellular outcome ( Figure 2F ). In contrast, very few CD45RA 2 were found in mice injected with pMPP cells, even though 325-fold more cells were injected. We conclude that pHSCs cultured in the presence of Notch signaling act as SCID-mouse repopulating cells (SRCs) 27 similar to freshly isolated HSCs. Figure 2B ).
Is Notch signaling required for the maintenance/expansion of HSCs in vivo?
We next tested whether this effect was also the case in vivo using competitive transplantation experiments. Equivalent numbers of sorted HSCs expressing either dnMaml-GFP 1 or YFP 1 were injected into sublethally irradiated neonatal NSG mice. Ten weeks later, the contribution of GFP-and/or YFP-expressing cells was analyzed in BM, thymus, and spleen. As shown in supplemental Figure 2A (left panels), the BM and spleen contained CD45 1 donor cells, which included GFP Effect of Notch engagement on the expansion of CD45RA subsets derived in vitro
We next examined the consequences of the Notch-driven expansion of HSCs on early progenitors, namely the CD45RA int and CD45RA hi fraction (as shown in Figure 1C) . We calculated the expansion of each progenitor fraction at weekly intervals based on the absolute number of cells recovered. Figure 4A shows that both CD45RA int and CD45RA
hi fractions expanded the most in the absence of Notch signals (Ctrl). In the presence of Notch signaling, the generation of (Figure 4 middle panels). These data suggest that a high or low level of Notch signaling expands CD45RA 2 and pHSCs, maintains them in an undifferentiated state, and restrains their differentiation into both CD45RA int and CD45RA hi progenitors.
Precursor-product relationship of CD45RA fractions derived in vitro
We next determined precursor-product relationships between CD45RA int and CD45RA hi fractions generated in vitro. CD45RA int were sorted from day 21 Ctrl, DL4 hi , and DL4 low cocultures and then recultured (new day 0) under the same conditions from which they were originally derived. As shown in Figure 4B , .80% of CD45RA int became CD45RA hi after only 2 days of further culture on Ctrl or DL4 low , but cells progressed more slowly to CD45RA hi when recultured in the presence of a high Notch signal. This indicated that CD45RA int were precursors of CD45RA hi cells. We concluded that CD45RA 2 give rise to CD45RA int and then to CD45RA hi , with Notch signaling restraining this developmental progression.
Functional characterization of progenitor cells: bulk and clonal assays
We next addressed the differentiation potential of CD45RA int and CD45RA hi subsets and examined their ability to generate colonyforming units (CFUs) in methylcellulose cultures. Figure 5A (top left panels) shows that CD45RA int cells derived from either Ctrl or DL4 low cultures gave rise to BFU-E, GM, G, and M colonies.
In striking contrast, very few if any BFU-E colonies were found in the CD45RA hi fraction from OP9-DL4 low or -Ctrl cultures. Nevertheless, CD45RA
hi cells have clear myeloid potential in that they gave rise to GM, G, and M colonies at higher frequencies than ex vivo MPP cells ( Figure 5A ). Therefore, CD45RA int and CD45RA hi cells both possess myeloid potential but CD45RA hi cells appear to have lost erythroid potential.
As shown in supplemental Figure 1A, Figure 1A and tested each fraction separately. Only the Rho int fraction gave rise to BFU-E although both fractions generated GM, G, and M CFU colonies ( Figure 5B) .
The lymphoid potential of CD45RA int and CD45RA hi cells generated in vitro was also assessed. The ability to generate T and B cells was observed in both CD45RA int ( Figure 5C ) and CD45RA hi cells ( Figure 5D ). The comparison of in vitro CD45RA int to ex vivo CD45RA int revealed that ex vivo CD45RA int also had T-and B-lineage potential ( Figure 5C ). However, a lower frequency of B cells was consistently found as compared with in vitro-derived CD45RA int cells. When ex vivo-derived CD45RA int Rho low/int cells were further fractionated into Rho low and Rho int cells, almost no B cells were generated in the Rho int fraction whereas the Rho low fraction did give rise to B cells ( Figure 5E ). To define the potential of these fractions at the clonal level, we repeated these analyses under limiting dilution conditions. We found that every single clone of CD45RA int and CD45RA hi was able to generate T cells regardless of the presence or absence of Notch signaling during the first 3 weeks of culture. Interestingly, T cells were also generated from ex vivo CD45RA int clones at a similar frequency ( Figure 5B ; supplemental Figure 3A , supplemental Tables  1 and 2 ). Additionally, B cells, as well as macrophages and granulocytes (supplemental Figure 3, Table 3) and given the T-cell frequencies observed (supplemental Table 2 ), our clonal analysis indicates that both CD45RA int and CD45RA hi cells were able to give rise to T, B, and myeloid cells. Therefore, a substantial fraction of both CD45RA int and CD45RA hi cells are lymphomyeloid precursors, the former compatible with an MPP.2 For personal use only. on April 14, 2017. by guest www.bloodjournal.org From type of cell and the latter with a lymphoid-primed MPP (LMPP) type of cell. 28 Ex vivo CD45RA int Rho low cells have a similar potential to in vitro-generated CD45RA hi cells (supplemental Figure 5 ). Therefore, ex vivo-derived CD45RA int Rho low cells are LMPP-like cells. However, ex vivo CD45RA int Rho int cells have the potential to generate at the clonal level GM, G, M, and T cells (supplemental Tables 1 and 2 ). Only a fraction of them also have in vitro erythroid potential. So, at least 2 subsets are present in ex vivo CD45RA int cells, a minority subset with erythromyeloid and lymphoid potential and a majority subset with myeloid and T-cell potential, but devoid of B and erythroid potential in vitro.
Molecular characterization of CD45RA subsets
To further characterize the in vitro-generated CD45RA int and CD45RA hi cells, we performed a quantitative polymerase chain reaction (qPCR) analysis. Figure 6 shows that DTX1 (Deltex1) was expressed only on CD45RA int and CD45RA hi cells grown from DL4 low cultures ( Figure 6 top left panel) consistent with Notch signaling in these cultures. GATA1 and GATA2 transcripts were expressed in CD45RA int cells but were present at low levels in CD45RA hi cells. GATA1 expression was high in CD45RA int cells from DL4 low cultures, which possessed a higher BFU-E frequency. On the other hand, IKZF1 (Ikaros) transcripts were expressed at higher levels in CD45RA hi cells from either Ctrl or DL4 low cultures.
This, together with the low levels of GATA1, confirmed a similar pattern of expression to that of mouse cells with similar differentiation potential. Additionally, SPI1 (PU.1), HOXB2, MLL3, and TAL1 (SCL) ( Figure 6 ) were expressed at higher levels in CD45RA int than in CD45RA hi cells from either Ctrl or DL4 low cultures, correlating with their earlier stage of differentiation. Taken together, the gene expression patterns found in both lymphomyeloid progenitors generated in vitro correspond to the pattern of gene expression predicted from their differentiation potential.
In vivo potential of in vitro-generated CD45RA int and CD45RA In contrast, mice injected with similar numbers of CD45RA int and CD45RA hi cells from Ctrl cultures were unable to effectively reconstitute the thymus, although they did reconstitute BM, with B and myeloid cells ( Figure 7A-B) . Notably, high levels of CD45 1 engraftment were seen in the thymus of 15 mice injected with CD45RA int from DL4 low cultures as compared with 7 mice injected with CD45RA int from Ctrl cultures ( Figure 7D ). Nonetheless, injection of higher numbers of these populations enabled CD45RA int and CD45RA hi cells from Ctrl cultures to reconstitute the thymus (data not shown). Thus, it appears that Notch signaling facilitated but was not required for thymic reconstitution. Lastly, ex vivo CD45RA int cells engrafted both the BM (B and myeloid cells) and thymus ( Figure 7C ). Results from 7 independent mice are presented in Figure 7D .
Discussion
We have defined culture conditions suitable for the maintenance of human HSCs, thus allowing us to directly test the effects of Notch signaling on prospectively defined HSCs. Here, we have found that HSCs are specifically affected by Notch signals in vitro, but do not rely on Notch signals for their expansion in vivo. In addition, our culture system enabled us to identify and characterize 2 new early progenitors, functionally akin to MPP-2 (CD45RA int ) and LMPP (CD45RA hi ) cells that were also found in CB. The role of Notch on HSCs remains controversial. In aggregate, our current understanding points to a dichotomy in the role of Notch in HSC expansion: in vitro systems support a role for both mouse HSCs 6 and human CD34 1 cells 4, 7, 8, 10, 29 while in vivo approaches discounted a role for mouse HSCs. 5 Mechanisms of how Notch signaling influence the maintenance and expansion of human HSCs in vitro vs in vivo are complex and difficult to dissect because they require discrete fractionation of the different HSC subsets. 4, 30 As described by Anjos-Afonso, 4 both the most primitive quiescent HSC (CD34
2
) and its progeny CD34 
CD49f
1 express DTX1 and HES1, display different kinetics of reconstitution, and appear to be affected differentially upon Notch inhibition in vivo.
Although a pharmacological inhibitor of Notch was used in this report, which is known to affect other nonhematopoietic tissues, maintenance and self-renewal of the CD34 2 subset was affected in vivo. 4 However, here we show that competitive transplantation experiments using dnMaml for Notch inhibition in HSCs possessed equal reconstitution abilities in vivo, consistent with the results in mice. 5 Nevertheless, whether loss of Notch signaling affected the temporal kinetics of reconstitution, as seen in mice, 31 was not addressed. A mechanism for how Notch signaling influences the maintenance and expansion of human HSCs in vitro is likely to involve several pathways regulated by Notch targets, such as cMyc, Cdkn1, and PTEN, all of which have been shown to affect HSC expansion/ maintenance. 32, 33 However, the dichotomy between the requirements for Notch in vitro vs its dispensable role in vivo is likely due to the complex nature of the BM niche, in which Notch signals may be only one of many factors, 17, 34, 35 while in vitro it becomes critically important. By removing HSCs from their normal BM niche, these cells would require a strong Notch signaling in vitro to compensate for the absence of the other signaling queues (supplemental Figure 4A ).
We also showed that both in vitro-derived phenotypically defined HSC (CD45RA 2 CD90 low ) and phenotypically defined MPP (CD45RA 2 CD90 2 ) populations were multipotent. However, upon transfer in to mice, in vitro-grown pHSCs were about 200 times more effective in generating CD45RA 2 cells than pMPPs, probably due to the fact that only CD90 low cells were able to self-renew in vivo. In this regard, we found that in vitro-derived pHSCs approximated the SRC activity of freshly isolated HSCs when directly compared. Given the variability associated with in vivo manipulations, the use of a xenogeneic model system, and the relatively low numbers of cells injected, we can estimate that the 2 populations are likely similar in function.
The immediate stages following the differentiation of human CB HSCs are not fully appreciated, nor are the precursor-product relationships between these early progenitors clearly established. We now show that Notch signaling appears to delay the differentiation of CD45RA 2 cells in vitro, as the appearance of downstream CD45RA int and CD45RA hi cells is inhibited by Notch signals. We next characterized and showed that CD45RA 2 cells gave rise to CD45RA int , then to CD45RA hi and then to CD45RA hi (CD10 1 ) cells (P.B., M.M., J.C.Z.-P., manuscript in preparation) in vitro, following a progression in which each fraction of lymphomyeloid progenitors corresponds to a more differentiated stage of development. CD45RA int cells obtained in vitro were shown at both population and clonal levels, and at the transcript level, to be functionally equivalent to phenotypically defined multipotent cells (pMPP-2), whereas the CD45RA hi cells qualify as LMPP-like cells. Both subsets were able to reconstitute the same lymphomyeloid lineages when injected into immune-deficient mice. Interestingly, both subsets could reconstitute the thymus of immune-deficient mice, but when these in vitro cells had received Notch signals thymic reconstitution was greatly facilitated. In the absence of Notch signaling, thymic reconstitution occurs but only when higher numbers of cells are injected. So, Notch signals facilitate but are not required for thymic reconstitution. Similar functional subsets were characterized in CB (ex vivo CD45RA int ). The presence of a weak erythroid differentiation potential in ex vivo Rho int CD45RA int suggests that this phenotypically defined subset of CB cells could include both MPP-2 and GMP precursor cells. 36 int subset that shares characteristics with our in vitrogenerated CD45RA
hi subset. The model presented in supplemental Figure 4B summarizes our findings. The human hematopoietic hierarchy appears similar to the murine system except for the fact that unlike the murine system, human pMPP-like cells with erythroid potential are able to reconstitute the thymus. We showed that the Notch-dependent maintenance of human pHSCs leads to an arrest in the differentiation of each of the lymphomyeloid progenitors (MPP-2 and LMPP) derived from it.
